文献速递外周动脉疾病

严重肢体缺血腔内治疗中逆行动脉入路的技术成功与并发症:系统综述与Meta分析

Technical Success and Complication Rates of Retrograde Arterial Access for Endovascular Therapy for Critical Limb Ischaemia: A Systematic Review and Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-12-24

结果显示逆行入路总体技术成功率为96%(95%CI 92%-100%),穿孔、限流性夹层、远端栓塞和局部血肿发生率分别为2.1%、0.6%、0.1%和1.3%,提示逆行或双向入路安全有效。

要点

  • 逆行入路治疗CLI总体技术成功率达96%(95%CI 92%-100%)。
  • 穿孔、限流性夹层、远端栓塞和局部血肿发生率低,分别为2.1%、0.6%、0.1%和1.3%。
  • 6个月一期通畅率78%(95%CI 46%-99%),6个月保肢率77%(95%CI 70%-84%)。

核心结论

  • 逆行或顺行/逆行双向入路安全有效,可在顺行治疗失败时辅助完成血管成形术。
  • 仍需前瞻性研究采用标准化伤口护理和监测方案,以改善CLI顺行血运重建失败患者的长期保肢和生存。

研究设计与样本

  • 系统检索PubMed、Scopus和Cochrane Central至2020年5月。
  • 纳入31项观察性研究(29项回顾性、2项前瞻性),采用随机效应模型进行Meta分析。

主要发现

  • 所有病变位于腹股沟下段,多数为慢性完全闭塞(96%;95%CI 85%-100%)。
  • 7项研究报告约半数病例存在中重度钙化(45%;95%CI 30%-60%)。
  • 总体技术成功率为96%(18项研究;95%CI 92%-100%)。
  • 穿孔、限流性夹层、远端栓塞和局部血肿发生率分别为2.1%、0.6%、0.1%和1.3%。
  • 6个月一期通畅率78%(5项研究;95%CI 46%-99%),6个月保肢率77%(4项研究;95%CI 70%-84%)。

临床怎么用

  • 对于CLI患者顺行入路失败时,可考虑逆行或双向入路完成腔内血运重建。
  • 逆行入路围手术期并发症发生率低,但需注意穿孔、夹层、远端栓塞和穿刺点血肿。

局限性

  • 纳入研究多为回顾性观察性研究,仅2项为前瞻性。
  • 6个月一期通畅率和保肢率的置信区间较宽,异质性可能较大。
  • 缺乏标准化伤口护理和监测方案的前瞻性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Antegrade crossing techniques via transfemoral access are often challenging and may be associated with technical and clinical failure when treating patients with critical limb ischaemia (CLI). The objective of this study was to summarise all available literature regarding retrograde endovascular treatment of patients with CLI and to investigate the technical success and complication rate of retrograde access. METHODS: A systematic literature search was performed in PubMed, Scopus, and Cochrane Central until May 2020. A meta-analysis of 31 observational studies (29 retrospective and two prospective; 26 and five studies with low and moderate risk of bias, respectively) was conducted with random effects modelling. The incidence of adverse events peri-procedurally and during follow up were calculated. RESULTS: The 31 studies enrolled 1 910 patients who were treated endovascularly for femoropopliteal and/or infrapopliteal lesions causing CLI. Most of the patients had diabetes while more than half of the overall population had coronary artery disease and dyslipidaemia. All lesions were located in the infra-inguinal segment and most were chronic total occlusions (96%; 95% CI 85%-100%). Seven studies reported moderate or severe calcification in approximately half of the cases (45%; 95% CI 30%-60%). The overall technical success of the retrograde approach was 96% (18 studies; 95% CI 92%-100%). Perforation, flow limiting dissection, distal embolisation, and local haematoma at the retrograde access site were infrequent and observed in 2.1%, 0.6%, 0.1%, and 1.3% of the patients, respectively. The six month primary patency rate was 78% (five studies; 95% CI 46%-99%), the six month limb salvage rate was 77% (four studies; 95% CI 70%-84%). CONCLUSION: The results indicated that the retrograde or bidirectional antegrade/retrograde approach is safe and effective and facilitates angioplasty when antegrade treatment fails. However, prospective studies with standardised wound care and surveillance protocols are needed to investigate retrograde techniques in patients with CLI who failed antegrade revascularisation, to improve long term limb salvage and survival.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Giannopoulos S, Palena LM, Armstrong EJ, et al. Technical Success and Complication Rates of Retrograde Arterial Access for Endovascular Therapy for Critical Limb Ischaemia: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2020. PMID: 33358346. doi:10.1016/j.ejvs.2020.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。